Library

Autor(en) Titel Quelle Links
Rachmilewitz EA, Giardina PJ How I treat thalassemia. Blood 2011, 118: 3479    
Radtke S, Zolk O, Renner B, Paulides M, Zimmermann M, Möricke A, Stanulla M, Schrappe M, Langer T Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity and outcome in childhood acute lymphoblastic leukemia. Blood 2013, Epub ahead of print    
Raimondi SC, Chang MN, Ravindranath Y Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999, 94: 3707    
Rajantie J, Zeller B, Treutiger I, Rosthöj S, NOPHO ITP working group and five national study groups Vaccination associated thrombocytopenic purpura in children. Vaccine 2007, 25: 1838    
Ramakers-van Woerden N, Pieters R, Loonen A, Hubeek I, van Drunen E, Beverloo H, Slater R, Harbott J, Seyfarth J, van Wering E, Hahlen K, Schmiegelow K, Janka-Schaub G, Veerman A TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000, 96: 1094    
Ramakers-van Woerden N, Pieters R, Slater R, Loonen A, Beverloo H, van Drunen E, Heyman M, Moreno T, Rots M, van Wering E, Kamps W, Janka-Schaub G, Veerman A In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia. Br J Haematol 2001, 112: 680    
Ramakers-van Woerden N, Pieters R, Hoelzer D, Slater R, Den Boer M, Loonen A, Harbott J, Janka-Schaub G, Ludwig W, Ossenkoppele G, van Wering E, Veerman A In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age. Med Pediatr Oncol 2002, 38: 379    
Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia 2004, 18: 521    
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of clinical oncology 2016 Jul 20; 34: 2468    
Raney B, Parham D, Sommelet-Olive D, Stevens M, Treuner J, Carli M Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10-12, 1994. Med Pediatr Oncol 1996, 26: 425    
Ranft A, Seidel C, Hoffmann C, Paulussen M, Warby AC, van den Berg H, Ladenstein R, Rossig C, Dirksen U, Rosenbaum D, Jürgens H Quality of Survivorship in a Rare Disease: Clinicofunctional Outcome and Physical Activity in an Observational Cohort Study of 618 Long-Term Survivors of Ewing Sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May 20; 35: 1704    
Rasper M, Jabar S, Ranft A, Jürgens H, Amler S, Dirksen U The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma. Pediatric blood & cancer 2014, 61: 1382    
Rasche M, von Neuhoff C, Dworzak M, Bourquin JP, Bradtke J, Göhring G, Escherich G, Fleischhack G, Graf N, Gruhn B, Haas OA, Klingebiel T, Kremens B, Lehrnbecher T, von Stackelberg A, Tchinda J, Zemanova Z, Thiede C, von Neuhoff N, Zimmermann M, Creutzig U, Reinhardt D Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004. Leukemia 2017, 31: 2807    
Rasche M, Zimmermann M, Borschel L, Bourquin JP, Dworzak M, Klingebiel T, Lehrnbecher T, Creutzig U, Klusmann JH, Reinhardt D Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia 2018, 32: 2167    
Ratei R, Sperling C, Karawajew L, Schott G, Schrappe M, Harbott J, Riehm H, Ludwig W Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Annals Hematology 1998, 77: 107    
Ratei R, Basso G, Dworzak M, Gaipa G, Veltroni M, Rhein P, Biondi A, Schrappe M, Ludwig WD, Karawajew L, AIEOP-BFM-FCM-MRD-Study Group Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction. Leukemia 2009, 23: 528    
Ratei R, Schabath R, Karawajew L, Zimmermann M, Möricke A, Schrappe M, Ludwig WD Lineage Classification of Childhood Acute Lymphoblastic Leukemia according to the EGIL Recommendations: Results of the ALL-BFM 2000 Trial. Klinische Padiatrie 2013, 225(S 01):S8    
Ravindranath Y, Abella E, Krischer JP, Wiley J, Inoue S, Harris M, Chauvenet A, Alvarado CS, Dubowy R, Ritchey AK et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 1992, 80: 2210    
Redlich A, Boxberger N, Strugala D, Frühwald MC, Leuschner I, Kropf S, Bucsky P, Vorwerk P Systemic Treatment of Adrenocortical Carcinoma in Children: Data from the German GPOH-MET 97 Trial. Klinische Padiatrie 2012, 224: 366    
Redlich A, Boxberger N, Kurt Werner S, Frühwald M, Rohrer T, Vorwerk P Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma. Pediatric blood & cancer 2012, 59: 233    
Rees DC, Williams TN, Gladwin MT Sickle-cell disease. Lancet 2010, 376: 2018-31.    
Rehan N, Bieling P, Winkler P, Helmke K, Maas R, Baldini N, Heise U, Fuchs N, Winkler K The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy. Klin Pädiatr 1993, 205: 200    
Reiter A, Schrappe M, Ludwig W, Lampert F, Harbott J, Henze G, Niemeyer C, Gadner H, Muller-Weihrich S, Ritter J, Favorable outcome of B-cell acute lymphoblastic leukemia in childhood. Blood 1992, 80: 2471    
Reiter A Therapy of B-cell acute lymphoblastic leukaemia in childhood. Baillieres Clin Haematol 1994, 7: 321    
Reiter A, Schrappe M, Ludwig W, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994, 84: 3122    
Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood. J Clin Oncol 1994, 12: 899    
Reiter A, Schrappe M, Yakisan E, Sauter S, Ebell W, Zimmermann M, Hartmann W, Kremens B, Kuhn N, Claviez A, Sauerbrey A, Riehm H NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3 Klin Pädiatr 1994, 206: 242    
Reiter A, Schrappe M, Yakisan E, Sauter S, Henzler D, Zimmermann M, Graf N, Fengler R, Kühl J, Fleischhack G, Dörffel W, Kluba U, Riehm H NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2 Klin Pädiatr 1994, 206: 234    
Reiter A, Tiemann M, Ludwig W, Wacker H, Yakisan E, Schrappe M, Henzler D, Sykora K, Brandt A, Odenwald E, Riehm H, Parwaresch R NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1 Klin Pädiatr 1994, 206: 222    
Reiter A, Zimmermann W, Zimmermann M, Schweinitz D, Riehm H, Mildenberger H The role of initial laparotomy and second-look surgery in the treatment of abdominal B-cell non-Hodgkin's lymphoma of childhood. A report of the BFM Group. Eur J Pediatr Surg 1994, 4: 74    
Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, Sykora K, Ludwig W, Gadner H, Riehm H Non-Hodgkin's lymphomas of childhood and adolescence. J Clin Oncol 1995, 13: 359    
Zur, Reiter A, Tomeczkowski J, Sykora K A non-radioactive method for detection of monoclonal cell populations in patients with Burkitt's Lymphoma. Molecular Biology of Hematopoiesis 1996, 159    
Reiter A Non-Hodgkin-Lymphome. Diagnostische und therapeutische Standards 1997, 89    
Reiter A, Riehm H Large-cell lymphomas in children. The Non-Hodgkin-Lymphomas 1997, 829    
Reiter A, Seidemann K, Schrappe M Therapie der Non-Hodgkin-Lymphome im Kindesalter. Klin Onkologie 1997, 16    
Zur, Reiter A, Welte K, Sykora K Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction. Klin Pädiatr 1997, 209: 165    
Reinhardt D, Pekrun A, Lakomek M, Ritter J, Creutzig U Isolierte Myelosarkome der Haut im Kindesalter. Monatsschrift Kinderheilkunde 1999, 147: 346    
Reinhardt D, Pekrun A, Lakomek M, Ritter J, Creutzig U Primary isolated myeolosarcoma in childhood. Klin Pädiatr 1999, 211: 245    
Reiter A, Schrappe M, Tiemann M, Ludwig W, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Müller-Weihrich S, Pluss H, Zintl F, Henze G, Riehm H Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy. Blood 1999, 94: 3294    
Reinhardt D, Pekrun A, Lakomek M, Zimmermann M, Ritter J, Creutzig U Primary myelosarcomas are associated with a high rate of relapse. Br J Haematol 2000, 110: 863    
Reiter A, Schrappe M, Ludwig W, Tiemann M, Parwaresch R, Zimmermann M, Schirg E, Henze G, Schellong G, Gadner H, Riehm H Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma. Blood 2000, 95: 416    
Reinhardt D, Lanvers C, Ritter J, and Creutzig U Acute promyelocytic leukemia in children – results of the AML-BFM 93/98 studie. Oncol 2001, 24    
Reinhardt D, Creutzig U Isolated myelosarcoma in children--update and review. Leuk Lymphoma 2002, 43: 565    
Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children. Klin Pädiatr 2002, 214: 188    
Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U Effektive Rezidivtherapie der akuten myeloischen Leukämie im Kindesalter mit liposomalem Daunorubicin und Cytarabin. Klinische Pädiatrie 2002, 214: 188    
Reinhardt D, Langebrake C, Creutzig U, Vormoor J, Brune C, Thorwesten M, Ingiliz P, Hrusak O, Dworzak M, Griesinger F Minimal residual disease in acute myeloid leukemia in children - standardization and evaluation of immunophenotyping in the AML-BFM-98 study. Klinische Pädiatrie 2002, 214: 179    
Reinhardt D, Puhlmann U, Vorwerk H, Creutzig U, Ziemann Ch Impact of Cyclooxygenase-2 Inhibitors on P-Glycoprotein-Mediated Multidrug Resistance in Acute Myeloid Leukemias in Childhood. Blood 2002, 100: 321a-321a    
Reinhardt D, Thiele C, Creutzig U Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation. Klin Pädiatr 2002, 214: 22    
Reinhardt D, Zimmermann M, Ritter J, Bender-Götze Ch, Creutzig U Comparison of Allogeneic Matched Related Stem Cell Transplantation in 1st CR with Chemotherapy alone in Children with High-Risk AML.    
Reinhardt D, Houliara K, Pekrun A, Lakomek M, Krone B Impact of Conventional Chemotherpy on Levels of Antibodies Against Vaccine-Preventable Diseases in Children Treated for Cancer. Scand J Infect Dis 2003, 35: 851    
Reiter A Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädi-atrische Onkologie und Hämatologie: Non-Hodgkin-Lymphome im Kindesalter. AWMF online 2003    
Reinhard H, Semler O, Burger D, Bode U, Flentje M, Göbel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter H, Stockle M, Thuroff J, Troger J, Weirich A, von Schweinitz D, Zoubek A, Graf N Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Pädiatr 2004, 216: 132    
Reinhardt D, Diekamp S, Fleischhack G, Corbacioglu S, Jürgens H, Dworzak M, Kaspers G, Creutzig U, Zwaan C Gemtuzumab Ozogamicin (Mylotarg©) in Children with Refractory or Relapsed Acute Myeloid Leukemia. Onkologie 2004, 27: 269    
Reinhardt D, Kurzknabe E, Löffler H, Creutzig U Akute Leukämien im Kindesalter mit besonderer Berücksichtigung der morphologischen Diagnostik. pädiatrische praxis 2004, 64: 395    
Reinhard H, Aliani S, Ruebe C, Stockle M, Leuschner I, Graf N Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004, 22: 4500    
Reinhardt D, Diekamp S, Langebrake C, Ritter J, Stary J, Dworzak M, Schrauder A, Zimmermann M, Fleischhack G, Ludwig WD, Harbott J, Creutzig U Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment. Leukemia 2005, 19: 1495    
Reinhardt D, Ritter J Klassifikation der Leukämien und malignen Lymphome. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 647    
Reinhardt D, Ritter J Reaktive Veränderungen des Blutbildes und des Knochenmarks. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 309    
Reiter A Non-Hodgkin-Lymphome im Kindesalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Pädiatrische Onkologie und Hämatologie 2006    
Reiter A, Mann G, Parwaresch R Non-Hodgkin-Lymphome. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie Berlin, Heidelberg, New York: Springer Verlag, 2006, 733    
Reiche R, Herold R Strukturen in der Pädiatrischen Onkologie und Hämatologie, Ergebnisse der wissenschaftlichen Begleitung der Jahre 2000 - 2006. Js. Karthaus GmbH & Co, Bonn 2007    
Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007, 39: 162    
Reiter A, Klapper W Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. British journal of haematology 2008, 142: 329    
Reinmuth S, Liebeskind AK, Wickmann L, Bockelbrink A, Keil T, Henze G, Borgmann A Having children after surviving cancer in childhood or adolescence - results of a Berlin survey. Klinische Padiatrie 2008, 220: 159    
Reinhard H, Reinert J, Beier R, Furtwängler R, Alkasser M, Rutkowski S, Frühwald M, Koscielniak E, Leuschner I, Kaatsch P, Graf N Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncology reports 2008, 19: 819    
Reimann, V Stammzellen aus Nabelschnurblut in der Transplantations- und regenerativen Medizin. Dtsch Arztebl 2009, 106: 831    
Reinhardt D, Reinhardt K, Neuhoff C, Sander A, Klusmann JH, Pekrun A, Sauerbrey A, von Stackelberg A, Rössig C, Creutzig U, Kolenova A [GATA1-Mutation Associated Leukemia in Children with Trisomy 21 Mosaic]. Klinische Padiatrie 2012, 224: 153    
Reinhardt D, Von Neuhoff C, Sander A, Creutzig U [Genetic Prognostic Factors in Childhood Acute Myeloid Leukemia]. Klinische Padiatrie 2012, 224: 372    
Reiter A Non-Hodgkin Lymphoma in Children and Adolescents. Klinische Padiatrie 2013, 225(S 01):S87-S93    
Reismüller B, Peters C, Dworzak MN, Pötschger U, Urban C, Meister B, Schmitt K, Dieckmann K, Gadner H, Attarbaschi A, Mann G, on behalf of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL): A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Journal of pediatric hematology/oncology 2013, Epub ahead of print    
Reinmuth S, Hohmann C, Rendtorff R, Balcerek M, Holzhausen S, Müller A, Henze G, Keil T, Borgmann-Staudt A Impact of chemotherapy and radiotherapy in childhood on fertility in adulthood: the FeCt-survey of childhood cancer survivors in Germany. Journal of cancer research and clinical oncology 2013, 139: 2071    
Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui CH High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet (London, England) 1999 Jul 3; 354: 34    
Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, Werft W, Breit S, Liu S, Engel F, Wittmann A, Zimmermann M, Stanulla M, Schrappe M, Ludwig WD, Bartram CR, Radlwimmer B, Muckenthaler MU, Lichter P, Kulozik AE High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16. 1 as a genomic marker for unfavorable early treatment response. Blood 2009, 114: 1053    
Remke M, Hering E, Gerber NU, Kool M, Sturm D, Rickert CH, Gerß J, Schulz S, Hielscher T, Hasselblatt M, Jeibmann A, Hans V, Ramaswamy V, Taylor MD, Pietsch T, Rutkowski S, Korshunov A, Monoranu CM, Frühwald MC Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Child's nervous system 2013, 29: 1253    
Renbarger JL, McCammack KC, Rouse CE, Hall SD Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatric blood & cancer 2008, 50: 769    
Renella R, Wood WG The congenital dyserythropoietic anemias. Hematology/oncology clinics of North America 2009, 23: 283    
Rendtorff R, Hohmann C, Reinmuth S, Müller A, Dittrich R, Beyer M, Wickmann L, Keil T, Henze G, Borgmann-Staudt A Hormone and Sperm Analyses after Chemo- and Radiotherapy in Childhood and Adolescence. Klinische Padiatrie 2010, 222: 145    
Rendtorff R, Beyer M, Müller A, Dittrich R, Hohmann C, Keil T, Henze G, Borgmann A Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors. Andrologia 2011, [Epub ahead of print]    
Reulen RC, Zeegers MP, Wallace WH, Frobisher C, Taylor AJ, Lancashire ER, Winter DL, Hawkins MM, British Childhood Cancer Survivor Study Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009, 18: 2239    
Rhodes MM, Bates DG, Andrews T, Adkins L, Thornton J, Denham JM Abdominal pain in children with sickle cell disease. Journal of clinical gastroenterology 2014, 48: 99    
Rickert CH, Strater R, Kaatsch P, Wassmann H, Jürgens H, Dockhorn-Dworniczak B, Paulus W Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 2001, 158: 1525    
Richter-Unruh A Pubertas präcox - Pubertas tarda bei Mädchen. ÄP Gynäkologie 4_2012    
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine : official journal of the American College of Medical Genetics 2015, 17: 405    
Ricklefs FL, Fritzsche F, Winkler B, Meissner B, Dührsen L, Westphal M, Rutkowski S, Martens T, Schüller U Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling. Child's nervous system 2019, 35: 1029    
Riehm H, Gadner H, Welte K Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes -Erfahrungsbericht nach 6 Jahren. Klin. Pädiat.1977 189; 89    
Riehm H, Gadner H, Langermann HJ, Odenwald E, Henze G The Berlin Childhood Acute lymphoblastic Leukemia Therapy Study, 1970-1976. Am J Pediatr Hematol Oncol 1980, 2: 299    
Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematology and blood transfusion 1990, 33: 439    
Rieden K, Weirich A, Tröger J, Ludwig R Tumor response to pre-operative chemotherapy in nephroblastoma. Advanced radiation therapy, tumor response monitoring and treatment planning 1992, 249    
Rieden K, Weirich A, Tröger J, Gamroth H, Raschke K, Ludwig R Accuracy of diagnostic imaging in nephroblastoma before preoperative chemotherapy. Eur Radiol 1993, 3: 115    
Riede UN (Hrsg) Allgemeine und spezielle Pathologie. Georg-Thieme-Verlag 5. komplett überarb. Aufl., 2004    
Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American journal of medical genetics. Part A 2017, 173: 1017    
Ritter J, Creutzig U, Riehm H, Schellong G Acute myelogenous leukemia. Recent Results Cancer Res 1984, 93: 204    
Ritter J, Creutzig U, Riehm H, Brandeis W, Gerein V, Prindull G, Rister M, Schellong G Improved treatment results in childhood acute myelogenous leukemia. Haematology and Blood Transfusion 1985, 29: 82    
Ritter J, Creutzig U, Schellong G Risikogruppen bei der akuten, nicht-lymphatischen Leukämie im Kindesalter. Analyse der Ergebnisse der kooperativen Therapiestudien AML-BFM-78 and 83. Onkologie 1986, 9: 78    
Ritter J, Creutzig U, Henze G, Jürgens H, Bode U, Prindull G, Schellong G High dosage ARA-C in combination with mitoxantrone in therapy of acute myeloid leukemia in childhood. Initial results of the AML BFM-85 recurrence study. Onkologie 1987, 10: 24    
Ritter J, Creutzig U, Hiddemann W, Schellong G Mitoxantron in Kombination mit hochdosiertem ARA-C als Therapiemöglichkeit bei der AML im Kindesalter. Fortschr antimikr antineoplast Chemother 6-9 1987, 1517-1521, 1987    
Ritter J, Voigt D, Hoese G, Schellong G Special aspects of supportive therapy in childhood acute leukemias. Haematol Bluttransfus 1987, 30: 182    
Ritter J Diagnostik und Therapie der akuten Leukämien. Onkol Forum Chemotherapie 1988, 2: 1    
Ritter J, Vormoor J, Creutzig U, Schellong G Prognostic significance of Auer rods in childhood acute myelogenous leukemia. Med Pediatr Oncol 1989, 17: 202    
Ritter J, Creutzig U, Jobke A, Lampert F, Reiter A, Schellong G Acute myelogenous leukemia in the first year of life. Contrib Oncol 1990, 41: 30    
Ritter J, Creutzig U, Reiter A, Riehm H, Schellong G Childhood leukemia. J Cancer Res Clin Oncol 1990, 116: 100    
Ritter J, Creutzig U, Schellong G Improved treatment results in the myelocytic subtypes FAB M1- M4 but not in FAB M5 after intensification of induction therapy. Haematology and Blood Transfusion 1990, 33: 185    
Ritterbach J, Harbott J, Ritter J, Lampert F Chromosomal aberrations in childhood acute nonlymphoblastic leukemia. Hamatol Bluttransfus 1990, 33: 153    
Ritter J, Creutzig U, Schellong G Treatment results of three consecutive German childhood AML trials. Leukemia 1992, 6: 59    
Ritter J, Creutzig U, Schellong G, Group for Treatment of refractory and relapsed childhood acute myelogenous leukemia with high dose cytosine arabinoside and mitoxantrone (HAM). Haematology and Blood Transfusion 1992, 34: 418    
Ritter J Diagnostic and therapy of systemic fungal infections in children with hematological malignancies. Res Clin Oncol 1994, 120    
Ritter J, Roos N Special aspects related to invasive fungal infections in children with cancer. Bailliere's Clin Inf Dis 1995, 2: 179    
Ritter J, Creutzig U, Zimmermann M The specific role of Idarubicin during Induction therapy of childhood AML. Haematology and Blood Transfusion 1996, 38: 396    
Ritter J Acute myeloid leukaemias. Eur J Cancer 1998, 34: 862    
Ritterbach J, Hiddemann W, Beck J, Schrappe M, Janka-Schaub G, Ludwig W, Harbott J, Lampert F Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). Leukemia 1998, 12: 427    
Ritter J, Schrappe M Theray of lymphoblastic leukemia. Paediatric Haematology 1999    
Ritterbusch H, Ehl, S Hämophagozytose Syndrom. Informationsblätter Primäre Immundefekte    
Rizzari C, Conter V, Starý J, Colombini A, Moericke A, Schrappe M Optimizing asparaginase therapy for acute lymphoblastic leukemia. Current opinion in oncology 2013, 25 Suppl 1:S1    
Rizzari C, Lanvers-Kaminsky C, Valsecchi MG, Ballerini A, Matteo C, Gerss J, Wuerthwein G, Silvestri D, Colombini A, Conter V, Biondi A, Schrappe M, Moericke A, Zimmermann M, von Stackelberg A, Linderkamp C, Frühwald MC, Legien S, Attarbaschi A, Reismüller B, Kasper D, Smisek P, Stary J, Vinti L, Barisone E, Parasole R, Micalizzi C, Zucchetti M, Boos J Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study. Haematologica 2019, 104: 1812    
Roach ES, Gomez MR, Northrup H Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998, 83: 624-8.    
Robison LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur DC, Hammond GD Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 1989, 63: 1904    
Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC, Children's Oncology Group Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. Journal of neurosurgery 2006, 105(6 Suppl): 444    
Robinson TM, Fuchs EJ Allogeneic stem cell transplantation for sickle cell disease. Current opinion in hematology 2016, 23: 524    
Rodriguez T, Baumgarten E, Fengler R, Soumpasis D, Henze G Long-term infusion of L-asparaginase--an alternative to intramuscular injection? Klin Pädiatr 1995, 207: 207    
Rodl R, Hoffmann C, Gosheger G, Leidinger B, Jürgens H, Winkelmann W Ewing's sarcoma of the pelvis. J Surg Oncol 2003, 83: 154    
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113: 2386    
Rodeghiero F, Ruggeri M Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? British journal of haematology 2012l; 158: 16    
Do BK, Rodger DC Sickle cell disease and the eye. Current opinion in ophthalmology 2017, 28: 623    
Roessner A, Jürgens H Round cell tumours of bone. Pathol Res Pract 1993, 189: 111    
Rossig C, Jürgens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria. Pediatric blood & cancer 2013, 60: 1574    
Rösler P, Christiansen H, Kortmann RD, Martini C, Matuschek C, Meyer F, Rübe C, Langer T, Koch R, Eich HT, Willich N, Steinmann D Hepatotoxicity after liver irradiation in children and adolescents : Results from the RiSK. Strahlentherapie und Onkologie 2015, 191: 413    
Rogge T, Niemeyer C Myelodysplastic syndromes in childhood. Onkologie 2000, 23: 18    
Rohrschneider W, Weirich A, Rieden K, Darge K, Troger J, Graf N US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol 1998, 28: 435    
Rohmer B, Valla FV, Baleydier F, Launay V, Dommange-Romero F, Pondarré C Newly Diagnosed Immune Thrombocytopenic Purpura in Childhood: Successful Implementation of a Limited Intervention Strategy in the Setting of Pediatric Emergency Care. The Journal of pediatrics 2014, Epub ahead of print    
Rohde M, Bonn BR, Zimmermann M, Lange J, Möricke A, Klapper W, Oschlies I, Szczepanowski M, Nagel I, Schrappe M, MMML-MYC-SYS Project, ICGC MMML-Seq Project, Loeffler M, Siebert R, Reiter A, Burkhardt B Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Muenster protocols. Haematologica 2017, 102: 1091    
Rokes CA, Remke M, Guha-Thakurta N, Witt O, Korshunov A, Pfister S, Wolff JE Sorafenib plus valproic acid for infant spinal glioblastoma. J Pediatr Hematol Oncol 2010, 32: 511    
Rolf N, Bugert P, Gehrisch S, Siegert G, Suttorp M, Knöfler R [Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy]. Hamostaseologie 2009, 29: 177    
Romanowski R, Schott C, Issels R, Klingebiel T, Treuner J, Jürgens H, Göbel U, Goldschmitt-Wuttge B, Feldmann H, Haas R Regional hyperthermia with systemic chemotherapy in children and adolescents. Klinische Pädiatrie 1993, 205: 249    
Ronceray L, Abla O, Barzilai-Birenboim S, Bomken S, Chiang AK, Jazbec J, Kabickova E, Lazic J, Beishuizen A, Mellgren K, Tanaka F, Pillon M, Devalck C, Gouttenoire M, Makarova O, Burkhardt B, Attarbaschi A, European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. Pediatric blood & cancer 2018, 65    
Ropero P, Arbeteta J, Nieto JM, González FA, González B, Villegas A, Benavente C Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene. Hemoglobin 2020, 1    
Rossi R, Helmchen U, Schellong G Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases. Eur J Pediatr 1992, 151: 384    
Rossi R, Ehrich J Partial and complete de Toni-Debre-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy. Eur J Clin Pharmacol 1993, 44 Suppl 1:S43-5:S43-S45    
Rossi R, Kleinebrand A, Godde A, Rath B, Jürgens H Increased risk of ifosfamide-induced renal Fanconi's syndrome after unilateral nephrectomy [letter]. Lancet 1993, 341    
Rossi R, Rath B, Ullrich K, Ehrich J Ifosfamide-induced nephrotoxicity. Monatsschr Kinderheilkd 1993, 141: 594    
Rossi R, Danzebrink S, Hillebrand D, Linnenburger K, Ullrich K, Jürgens H Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994, 22: 27    
Rossi R, Danzebrink S, Linnenburger K, Hillebrand D, Gruneberg M, Sablitzky V, Deufel T, Ullrich K, Harms E Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 1994, 83: 1282    
Rossi R, Godde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, Jürgens H Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity. J Clin Oncol 1994, 12: 159    
Rossi R, Kist C, Wurster U, Kulpmann W, Ehrich J Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatr Nephrol 1994, 8: 151    
Rossi R, Godde A, Kleinebrand A, Rath B, Jürgens H Concentrating capacity in ifosfamide-induced severe renal dysfunction. Ren Fail 1995, 17: 551    
Rossi R Nephrotoxicity of ifosfamide--moving towards understanding the molecular mechanisms [editorial]. Nephrol Dial Transplant 1997, 12: 1091    
Rossi R, Schäfers P, Pleyer J, Postler Ch, Boos J, Jürgens H The influence of short versus continious ifosfamide infusion on the development of renal tubular impairment. J Ped Hematol/Oncol 1997, 4: 393    
Rossi R, Kleta R, Ehrich J Renal involvement in children with malignancies. Pediatr Nephrol 1999, 13: 153    
Rossi R, Pleyer J, Schäfers P, Kuhn N, Kleta R, Deufel T, Jürgens H Development of ifosfamide-induced nephrotoxicity. Med Pediatr Oncol 1999, 32: 177    
Rosenthal H, Kolb R, Gratz K, Reiter A, Galanski M Bone manifestations in non-Hodgkin's lymphoma in childhood and adolescence. Radiologe 2000, 40: 737    
Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI, NOPHO ITP Working Group Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. The Journal of pediatrics 2003, 143: 302    
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC, Severe Chronic Neutropenia International Registry The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107: 4628    
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. British journal of haematology 2010, 150: 196    
Rossig C, Jürgens H, Schrappe M, Moericke A, Henze G, von Stackelberg A, Reinhardt D, Burkhardt B, Woessmann W, Zimmermann M, Gadner H, Mann G, Schellong G, Mauz-Koerholz C, Dirksen U, Bielack S, Berthold F, Graf N, Rutkowski S, Calaminus G, Kaatsch P, Creutzig U Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria. Pediatric blood & cancer 2013, 60: 1574    
Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS Revised International Pediatric Non-Hodgkin Lymphoma Staging System. Journal of clinical oncology 2015, 33: 2112    
Roth H, Weirich A, Ludwig R, Daum R, Zimmermann H Resection of nephroblastoma. Langenbecks Arch Chir Suppl Kongressbd 1996, 113: 1078    
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Kaspers G, Hählen K, Creutzig U, Veerman A, Jansen G Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates. Blood 1999, 54: 3121    
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Kaspers G, Hählen K, Creutzig U, Veerman A, Jansen G Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accummulation and polyglutamylation in childhood leukemia. Blood 1999, 93: 1677    
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Henze G, Janka-Schaub G, Veerman A, Jansen G Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2000, 109: 629    
Rots M, Pieters R, Peters G, Noordhuis P, van Zantwijk C, Henze G, Janka-Schaub G, Veerman A, Jansen G Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2000, 109: 629    
Rots M, Pieters R, Jansen G, Kaspers G, van Zantwijk C, Noordhuis P, Voorn D, van Wering E, Creutzig U, Veerman A, Peters G A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia. Eur J Cancer 2001, 37: 492    
Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, Müller HL Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res 2007, 61: 496    
Roth CL, Gebhardt U, Müller HL Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity 2011, 19: 36    
Royer-Pokora B, Graf N Wilms tumors arising at young age: a genetic basis to distinguish subgroups for individualized therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 1; 29:e485-6; author reply e487    
Rozen WM, Joseph S, Lo PA Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. Pediatric neurosurgery 2008, 44: 324    
Rube C, van Valen F, Wilfert F, Palm J, Schuck A, Willich N, Winkelmann W, Jürgens H, Rube C Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (tnf-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys 2003, 56: 1414    
Rudolph P, Lappe T, Hero B, Berthold F, Parwaresch R, Harms D, Schmidt D Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol 1997, 150: 133    
Rudnik-Schoneborn S, Anhuf D, Koscielniak E, Zerres K Alveolar rhabdomyosarcoma in infantile spinal muscular atrophy: coincidence or predisposition? Neuromuscular disorders 2005, 15: 45    
Rühl U, Albrecht M, Dieckmann K, Lüders H, Marciniak H, Schellenberg D, Wickmann L, Dörffel W Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease. Int J Radiation Oncology Biol Phys 2001, 51: 1209    
Ruf S, Brugieres L, Pillon M, Zimmermann M, Attarbaschi A, Melgrenn K, Williams D, Uyttebroeck A, Wrobel G, Reiter A, Woessmann W Risk-adapted therapy for patients with relapsed or refractory ALCL - final report of the prospective ALCL-Relapse Trial of the EICNHL. Br J Haematol 2015, 171: 45    
Ruf S, Hebart H, Hjalgrim LL, Kabickova E, Lang P, Steinbach D, Schwabe GC, Woessmann W CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series. Pediatric blood & cancer 2018, 65:e27003    
Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov 1; 29: 4151    
Ruggeri A, Michel G, Dalle JH, Caniglia M, Locatelli F, Campos A, Diaz de Heredia C, Mohty M, Perez Hurtado JM, Bierings M, Bittencourt H, Mauad M, Purtill D, Cunha R, Kabbara N, Gluckman E, Labopin M, Peters C, Rocha V Impact of pre-transplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission. An Eurocord, PDWP-EBMT analysis. Leukemia 2012, [Epub ahead of print]    
Ruhnke M, Rickerts V, Cornely OA, Buchheidt D, Glöckner A, Heinz W, Höhl R, Horré R, Karthaus M, Kujath P, Willinger B, Presterl E, Rath P, Ritter J, Glasmacher A, Lass-Flörl C, Groll AH Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011 54: 279    
Ruland V, Hartung S, Kordes U, Wolff JE, Paulus W, Hasselblatt M Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis. Genes, chromosomes & cancer 2014, 53: 373    
Rund D, Rachmilewitz E Beta-thalassemia. The New England journal of medicine 2005, 353: 1135    
Rustler V, Hagerty M, Daeggelmann J, Marjerrison S, Bloch W, Baumann FT Exercise interventions for patients with pediatric cancer during inpatient acute care: A systematic review of literature. Pediatric blood & cancer 2017, 64    
Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. Br J Cancer 2004, 91: 1656    
Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. The New England journal of medicine 2005, 352: 978    
Rutkowski S, Warmuth-Metz M, Sörensen N, Faldum A, Pietsch T, Müller H, Gnekow A, Göbel U, Wolff J, Fleischhack G, Kortmann R Hirntumoren im Kindesalter. Diagnostik und interdisziplinäre Therapiekonzepte. Der Onkologe Band 2005, Heft 10,    
Rutkowski S Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother 2006, 6: 1211    
Rutkowski S Timely identification of suspected paediatric CNS tumours. The lancet oncology 2007, 8: 664    
Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Clinical cancer research 2007, 13: 2651    
Rutkowski S, Riehle E Access to employment and economic independence in cerebral palsy. Physical medicine and rehabilitation clinics of North America 2009, 20: 535    
Rutkowski S, Gerber NU, von Hoff K, Gnekow A, Bode U, Graf N, Berthold F, Henze G, Wolff JE, Warmuth-Metz M, Soerensen N, Emser A, Ottensmeier H, Deinlein F, Schlegel PG, Kortmann RD, Pietsch T, Kuehl J, German Pediatric Brain Tumor Study Group Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-oncology 2009, 11: 201    
Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML, Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 2010, 28: 4961    
Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J Medulloblastoma in young children. Pediatr Blood Cancer 2010, 54: 635    
Rutkowski S, Trollmann R, Korinthenberg R, Warmuth-Metz M, Weckesser M, Krauss J, Pietsch T Leitsymptome und Diagnostik der ZNS-Tumoren im Kindes- und Jugendalter. Gemeinsame Leitlinie der Gesellschaft für Neuropädiatrie und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2016    
Rutkowski S Medulloblastom im Kindes- und Jugendalter. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie. AWMF online 2018    
Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P, Duarte R, Peters C, Garderet L, Schönland S, Gratwohl A, Niederwieser D, de Witte T, Kröger N Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant 2015, 50: 1542    
189 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.